Carcinogenicity of proposed cancer chemotherapeutic agents with stilbene-arylnitrosamine structures.
D000230:Adenocarcinoma / Q000139:chemically induced; D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D001593:Benzyl Compounds / Q000633:toxicity; D001943:Breast Neoplasms / Q000139:chemically induced; D002273:Carcinogens; D004428:Ear Neoplasms / Q000139:chemically induced; D005260:Female; D007192:Indenes / Q000633:toxicity*; D007680:Kidney Neoplasms / Q000139:chemically induced; D008113:Liver Neoplasms / Q000139:chemically induced; D008175:Lung Neoplasms / Q000139:chemically induced; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D009602:Nitrosamines / Q000633:toxicity*; D011804:Quinolines / Q000633:toxicity; D051381:Rats; D013343:Styrenes / Q000633:toxicity*
D000970:Antineoplastic Agents; D001593:Benzyl Compounds; D002273:Carcinogens; D007192:Indenes; D009602:Nitrosamines; D011804:Quinolines; D013343:Styrenes